-
公开(公告)号:US20210108268A1
公开(公告)日:2021-04-15
申请号:US15733628
申请日:2019-03-22
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Timothy LOONEY
IPC: C12Q1/6886
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, methods provide for determining convergence of T cell receptor and/or B cell receptor repertoires in samples prior to a treatment and predicting a subjects response to the treatment based on the measured convergence frequency. In another aspect, methods provide for an immune receptor haplotype group and predicting a subjects potential or predisposition to be protected from or vulnerable to an adverse event following a treatment.
-
公开(公告)号:US20220073983A1
公开(公告)日:2022-03-10
申请号:US17250406
申请日:2019-07-18
Applicant: Life Technologies Corporation
Inventor: Timothy LOONEY , Chenchen YANG , Geoffrey LOWMAN
IPC: C12Q1/6881 , C12N15/10
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, target-specific primer panels provide for the effective amplification of nucleic acid sequences of murine T cell receptor and/or B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Variable regions associated with the immune cell receptor are resolved to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US20210164047A1
公开(公告)日:2021-06-03
申请号:US17248722
申请日:2021-02-04
Applicant: Life Technologies Corporation
Inventor: Timothy LOONEY , Geoffrey LOWMAN , Lifeng LIN
IPC: C12Q1/6876 , C12Q1/6869 , C12Q1/6844 , C12Q1/6811 , C12Q1/6881 , C12Q1/6883 , C40B50/06
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, target-specific primer panels provide for the effective amplification of sequences of T cell receptor and/or B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Variable regions associated with the immune cell receptor are resolved to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US20190085374A1
公开(公告)日:2019-03-21
申请号:US16120045
申请日:2018-08-31
Applicant: Life Technologies Corporation
Inventor: Geoffrey LOWMAN , Timothy LOONEY , Lifeng LIN , Elizabeth LINCH , Lauren MILLER
IPC: C12Q1/686 , C12Q1/6806 , C12Q1/6869 , C40B50/00
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire using genomic DNA from a biological sample. In one aspect, target-specific primer panels provide for the effective amplification of sequences of T cell receptor and/or B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Nucleic acid sequences of variable regions associated with the immune cell receptor are determined to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US20210285027A1
公开(公告)日:2021-09-16
申请号:US17302638
申请日:2021-05-07
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Geoffrey LOWMAN , Timothy LOONEY , Lifeng LIN , Elizabeth LINCH , Lauren MILLER
IPC: C12Q1/686 , C40B50/06 , C12Q1/6806 , C12Q1/6869 , C40B50/00
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire using genomic DNA from a biological sample. In one aspect, target-specific primer panels provide for the effective amplification of sequences of T cell receptor and/or B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Nucleic acid sequences of variable regions associated with the immune cell receptor are determined to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US20180208984A1
公开(公告)日:2018-07-26
申请号:US15873862
申请日:2018-01-17
Applicant: Life Technologies Corporation
Inventor: Timothy LOONEY , Geoffrey LOWMAN , Lifeng LIN
IPC: C12Q1/6876 , C12Q1/6869 , C12Q1/6844 , C12Q1/6811
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, target-specific primer panels provide for the effective amplification of sequences of T cell receptor and/or B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Variable regions associated with the immune cell receptor are resolved to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US20220002802A1
公开(公告)日:2022-01-06
申请号:US17250408
申请日:2019-07-18
Applicant: Life Technologies Corporation
Inventor: Timothy LOONEY , Geoffrey LOWMAN , Lifeng LIN , Chenchen YANG
IPC: C12Q1/6881 , C12N15/10
Abstract: The present disclosure provides methods, compositions, kits, and systems useful in the determination and evaluation of the immune repertoire. In one aspect, target-specific primer panels provide for the effective amplification of sequences of B cell receptor chains with improved sequencing accuracy and resolution over the repertoire. Variable regions associated with the immune cell receptor are resolved to effectively portray clonal diversity of a biological sample and/or differences associated with the immune cell repertoire of a biological sample.
-
公开(公告)号:US20200335176A1
公开(公告)日:2020-10-22
申请号:US16851472
申请日:2020-04-17
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Fiona Hyland , Asha KAMAT , Timothy LOONEY
IPC: G16B20/20 , G06N3/12 , G06F16/2457 , G06F16/248
Abstract: The method includes compressing numbers of reads data for targeted genes of a gene expression assay performed on a test sample. The targeted genes are organized into categories. Each category represents a functional context associated with the targeted genes in that category. The numbers of reads corresponding to targeted genes each category is compressed to form a compressed value for the category. The compressed value is compared to a baseline value for the category to determine an enrichment or a loss of a signature corresponding to the functional context of the category. The method may include analyzing information from multiple assays performed on the test sample, assigning a score value to each assay result and predicting a response to immune-oncology treatment based on the assigned scores.
-
-
-
-
-
-
-